1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nephropathy Global Clinical Trials Review, H2, 2015

Nephropathy Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 76 pages

Nephropathy Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Nephropathy Global Clinical Trials Review, H2, 2015" provides an overview of Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Nephropathy Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nephropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Nephropathy 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Nephropathy Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Mallinckrodt Plc 37
Clinical Trial Overview of Mallinckrodt Plc 37
Rigel Pharmaceuticals, Inc. 38
Clinical Trial Overview of Rigel Pharmaceuticals, Inc. 38
AstraZeneca Plc 39
Clinical Trial Overview of AstraZeneca Plc 39
Cumberland Pharmaceuticals, Inc. 40
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 40
Astellas Pharma Inc. 41
Clinical Trial Overview of Astellas Pharma Inc. 41
Anthera Pharmaceuticals‚ Inc. 42
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 42
AbbVie Inc. 43
Clinical Trial Overview of AbbVie Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Mayo Clinic 44
Clinical Trial Overview of Mayo Clinic 44
Leiden University Medical Center 45
Clinical Trial Overview of Leiden University Medical Center 45
Nanjing Medical University 46
Clinical Trial Overview of Nanjing Medical University 46
Ospedale Misericordia e Dolce 47
Clinical Trial Overview of Ospedale Misericordia e Dolce 47
Regional Hospital Holstebro 48
Clinical Trial Overview of Regional Hospital Holstebro 48
Seoul National University Hospital 49
Clinical Trial Overview of Seoul National University Hospital 49
Radboud University 50
Clinical Trial Overview of Radboud University 50
Tehran University of Medical Sciences 51
Clinical Trial Overview of Tehran University of Medical Sciences 51
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
A. Manzoni Hospital 53
Clinical Trial Overview of A. Manzoni Hospital 53
Five Key Clinical Profiles 54
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 76

List of Tables
Nephropathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nephropathy Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nephropathy Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Nephropathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Nephropathy Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mallinckrodt Plc, 2015* 37
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015* 38
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 39
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015* 40
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 41
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2015* 42
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 44
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 45
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2015* 46
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Misericordia e Dolce, 2015* 47
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regional Hospital Holstebro, 2015* 48
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 49
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 50
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 51
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 52
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Manzoni Hospital, 2015* 53

List of Figures
Nephropathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nephropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.